Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Blood NAD Levels May Offer Clues to Cardiovascular Health

By LabMedica International staff writers
Posted on 17 Nov 2026

Nicotinamide adenine dinucleotide (NAD) is an essential molecule involved in cellular metabolism and energy production. More...

Blood NAD has attracted attention because NAD-boosting supplements are promoted for healthy aging, yet human blood findings have been inconsistent. The key diagnostic question is whether whole-blood NAD reflects normal aging or disease-related biology. New findings demonstrate that whole-blood NAD levels are linked to cardiovascular disease rather than declining universally with age.

Vilnius University researchers evaluated whole-blood NAD measurement in 1,068 adults, including healthy individuals and people with chronic diseases. The study included 1,340 NAD measurements obtained from dried blood spot samples collected under standardized conditions. The analysis examined whether NAD levels change with chronological age and whether chronic disease status is associated with differences in measured levels.

Among healthy adults, whole-blood NAD did not decline with age. Levels remained stable in men and increased modestly but significantly in women. In contrast, NAD levels were lower in people with cardiovascular disease, with the clearest differences observed among participants with hypertension.

The findings were published in Nature Metabolism and challenge the assumption that declining blood NAD is a universal feature of human aging. The researchers emphasized that the study does not establish whether lower NAD contributes to cardiovascular disease, results from the disease, or reflects other underlying factors. They also stated that the study does not show that increasing NAD through supplementation can prevent or treat cardiovascular disease or hypertension.

The work also addressed whether blood NAD can reflect NAD levels in tissues such as muscle or the brain. A commentary published alongside the study highlighted limitations of using blood NAD as a proxy for tissue NAD because red blood cells account for most whole-blood NAD and have different metabolic characteristics from other cell types. The researchers noted that blood biomarkers can still provide clinically useful information, and identified future work on cardiovascular risk prediction and mechanisms linking NAD levels with cardiovascular disease as the next step.

“For years, the prevailing narrative has been that NAD declines as we age and therefore needs to be restored. Our findings suggest that this is not what happens in the blood of healthy adults,” said Dr. Dalius Ratautas, who led the research at Vilnius University. 

“Instead, we found a clear association between lower NAD levels and cardiovascular disease. This raises a different and potentially important question: could NAD levels tell us something about cardiovascular health?” added Dr. Ratautas.

Related Links
Vilnius University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Drug Testing Assays
Atellica DT 250 Analyzer
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.